Sensing Levofloxacin with an RNA Aptamer as a Bioreceptor.
Janice KramatLeon KrausVincent J GunawanElias SmyejPhilipp FroehlichTim E WeberDieter SpiehlHeinz KoepplAndreas BlaeserBeatrix SuessPublished in: Biosensors (2024)
To combat the growing threat of antibiotic resistance, environmental testing for antibiotic contamination is gaining an increasing role. This study aims to develop an easy-to-use assay for the detection of the fluoroquinolone antibiotic levofloxacin. Levofloxacin is used in human and veterinary medicine and has been detected in wastewater and river water. An RNA aptamer against levofloxacin was selected using RNA Capture-SELEX. The 73 nt long aptamer folds into three stems with a central three-way junction. It binds levofloxacin with a K d of 6 µM and discriminates the closely related compound ciprofloxacin. Furthermore, the selection process was analyzed using a next-generation sequencing approach to better understand the sequence evolution throughout the selection. The aptamer was used as a bioreceptor for the development of a lateral flow assay. The biosensor exploited the innate characteristic of RNA Capture-SELEX to select aptamers that displace a complementary DNA oligonucleotide upon ligand binding. The lateral flow assay achieved a limit of visual detection of 100 µM. While the sensitivity of this assay constrains its immediate use in environmental testing, the present study can serve as a template for the selection of RNA aptamer-based biosensors.
Keyphrases
- label free
- gold nanoparticles
- sensitive detection
- nucleic acid
- high throughput
- magnetic nanoparticles
- loop mediated isothermal amplification
- immune response
- risk assessment
- endothelial cells
- human health
- circulating tumor
- pseudomonas aeruginosa
- heavy metals
- cell free
- wastewater treatment
- induced pluripotent stem cells
- dna methylation
- genome wide
- climate change
- health risk
- circulating tumor cells
- cystic fibrosis